Molecular Population Genetic Analysis of Emerged Bacterial Pathogens: Selected Insights

Emerging Infectious Diseases

Volumn 2, Issue 1, 1996, Pages 1-17

  Musser, James M ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Clinical Microbiology Laboratory

^c Methodist Hospital

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; ESCHERICHIA COLI; GENETICS; HAEMOPHILUS INFLUENZAE; MYCOBACTERIUM TUBERCULOSIS; POPULATION GENETICS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

BACTERIA; ESCHERICHIA COLI; GENETICS, POPULATION; HAEMOPHILUS INFLUENZAE; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0029682343     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0201.960101     Document Type: Review

References (164)

1. Milkman R. Electrophoretic variation in Escherichia coli from natural sources. Science 1973;182:1024-6.
2. Selander RK, Levin BR. Genetic diversity and structure in Escherichia coli populations. Science 1980;210:545-7.
3. Lewontin RC. The genetic basis of evolutionary change. New York: Columbia University Press, 1974.
4. Kimura M. The neutral theory of molecular evolution. New York: Cambridge University Press, 1983.
5. Nei M. Molecular evolutionary genetics. New York: Columbia University Press, 1987.
6. Baumberg S, Young JPW, Wellington EMH, Saunders JR, editors. Population genetics of bacteria. Cambridge, UK: Cambridge University Press, 1995.
7. Taylor J, Powell BW, Wright J. Infantile diarrhoea and vomiting: a clinical and bacteriological investigation. Br Med J [Clin Res] 1949; 2:117-25.
8. Orskov F, Orskov I. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J Infect Dis 1983; 148:346-57.
9. Orskov F, Orskov I, Evans DJ, Sack RB, Wadstrom T. Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol 1976; 162:73-80.
10. Lewontin RC. Twenty-five years ago in genetics: electrophoresis in the development of evolutionary genetics: milestone or millstone? Genetics 1991;128:657-62.
11. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam S. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986;51:873-84.
12. Dykhuizen D, Hartl DL. Selective neutrality of 6PGD allozymes in E. coli and the effects of genetic background. Genetics 1980;96:801-17.
13. Whittam TS, Oehman H, Selander RK. Multilocus genetic structure in natural populations of Escherichia coli. Proc Natl Acad Sci USA 1983;80:1751-5.
14. Dykhuizen DE, de Framond J, Hartl DL. Selective neutrality of glucose-6-phosphate dehydrogenase allozymes in Escherichia coli. Mol Biol Evol 1984;1:162-70.
15. Ochman H, Whittam TS, Caugant DA, Selander RK. Enzyme polymorphism and genetic structure in Escherichia coli and Shigella. J Gen Microbiol 1983;129:2715-26.
16. Selander RK, McKinney RM, Whittam TS, Bibb WF, Brenner DJ, Nolte FS, et al. Genetic structure of populations of Legionella pneumophila. J Bacteriol 1985;163:1021-37.
17. Musser JM, Hewlett EL, Peppier MS, Selander RK. Genetic diversity and relationships in populations of Bordetella spp. J. Bacteriol 1986;166:230-7.
18. Gilmour MN, Whittam TS, Kilian M, Selander RK. Genetic relationships among the oral streptococci. J Bacteriol 1987:5247-57.
19. Brenner DJ, Steigerwalt AG, Epple P, Bibb WF, McKinney RM, Starnes RW, et al. Legionella pneumophila serogroup Lansing 3 isolated from a patient with fatal pneumonia, and descriptions of L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei subsp. nov. J Clin Microbiol 1988;26:1695-1703.
20. Musser JM, Barenkamp SJ, Granoff DM, Selander RK Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun 1986;55:183-91.
21. Quentin R, Goudeau A, Wallace RJ, Jr, Smith AL, Selander RK, Musser JM. Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol 1990;136:1203-9.
22. Versalovic J, Swanson DS, Musser JM. Nucleic acid sequencing studies of microbial pathogens: insights into epidemiology, virulence, drug resistance, and diversity. In: Persing DH, editor. PCR Application for Emerging Infectious Diseases. Washington DC: American Society for Microbiology. In press.
23. Brazilian Purpuric Fever Study Group. Brazilian purpuric fever: epidemic purpura fulminans associated with antecedent purulent conjunctivitis. Lancet 1987;2:757-61.
24. Brazilian Purpuric Fever Study Group. Haemophilus aegyptius bacteremia in Brazilian purpuric fever. Lancet 1987;2:761-3.
25. Brenner DJ, Mayer LW, Carlone GM, et al. Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (H. aegyptius) strains associated with Brazilian purpuric fever. J Clin Microbiol 1988;26:1524-34.
26. Musser JM, Selander RK. Brazilian purpuric fever: evolutionary genetic relationships of the case clone of Haemophilus influenzae biogroup aegyptius to encapsulated strains of Haemophilus influenzae. J Infect Dis 1990;161:130-3.
27. Mulks MH, Kornfeld SJ, Fragione B, Plaut AG. Relationship between the specificity of IgA proteases and serotype in Haemophilus influenzae. J Infect Dis 1982;146:266-74.
28. Carlone GM, Gorelkin L, Gheesling LL, et al. Potential virulence-associated factors in Brazilian purpuric fever. J Clin Microbiol 1989;27:609-14.
29. Rubin LG. Phase-variable expression of the 145-kDa surface protein of Brazilian purpuric fever case-clone strains of Haemophilus influenzae biogroup aegyptius. J Infect Dis 1995;171:713-7.
30. Whitney AM, Farley MM. Cloning and sequence analysis of the structural pilin gene of Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius. Infect Immun 1993;1559-62.
31. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983;308:681-5.
32. Feng P. Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants. Emerging Infect Dis 1995;1:47-52.
33. Whittam TS, Wachsmuth IK, Wilson RA. Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 1988;157:1124-33.
34. Whittam TS, Wolfe ML, Wachsmuth IK, Orskov F, Orskov I, Wilson RA. Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun 1993;61:1619-29.
35. Whittam TS. Genetic population structure and pathogenicity in enteric bacteria. In: Baumberg S, Young JPW, Saunders SR, Wellington EMH, editors. Population genetics of bacteria. London: Cambridge University Press, 1995:217-45.
36. Bohm H, Karch H. DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis. J Clin Microbiol 1992;30:2169-72.
37. Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol 1992;6:411-7.
38. Knutton S, Baldwin T, Williams PH, McNeish AS. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 1989;57:1290-8.
39. Law D. Adhesion and its role in the virulence of enteropathogenic Escherichia coli. Clin Microbiol Rev 1994;7:152-73.
40. Selander RK, Caugant DA, Whittam TS. Genetic structure and variation in natural populations of Escherichia coli. In: Neidhardt FC, Ingraham JL, Low KB, Magasanik B, Schaechter M, Umbarger HE, editors. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, DC: American Society for Microbiology, 1987:1625-48.
41. Caugant DA, Levin BR, Orskov I, Orskov F, Svanborg Eden C, Selander RK. Genetic diversity in relation to serotype in Escherichia coli. Infect Immun 1985;49:407-13.
42. Achtman M, Pluschke G. Clonal analysis of descent and virulence among selected Escherichia coli. Annu Rev Microbiol 1986;40:185-210.
43. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978;ii:1116-8.
44. Davis JP, Chesney PJ, Wand PJ, LaVenture M, and Investigation and Laboratory Team. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429-35.
45. Bonventre PF, Weckbach L, Harth G, Haidaris C. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin. Rev Infect Dis 1989;11:890-96.
46. deAzavedo JCS. Animal models for toxic shock syndrome: overview. Rev Infect Dis 1989;11:S205-9.
47. Musser JM, Schlievert PM, Chow AW, et al. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci USA 1990;87:225-9.
48. See RH, Chow AW. Microbiology of toxic shock syndrome: overview. Rev Infect Dis 1989;11:S55-S60.
49. Kreiswirth BN. Genetics and expression of toxic shock syndrome toxin 1: overview. Rev Infect Dis 1989;S97-S100.
50. Lee PK, Kreiswirth BN, Deringer JR, et al. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from bovine- and bovine-associated Staphylococcus aureus. J Infect Dis 1992;165:1056-63.
51. Goh S-H, Byrne SK, Zhang JL, Chow AW. Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 1992;30:1642-5.
52. Caugant DA, Froholm LO, Bovre K, Holten E, Frasch CE, Moeca LF, Zollinger WD, Selander RK. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA 1986;83:4927-31.
53. Reeves MW, Perkins BA, Diermayer M, Wenger JD. Epidemic- associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerging Infect Dis 1995;1:53-4.
54. Tavares Sacchi C, Pessoa LL, Ramos SR, et al. Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, Due to increased prevalence of a single clone of the ET-5 complex. J Clin Microbiol 1992;30:1734-8.
55. Caugant DA, Bol P, Hoiby EA, Zanen HC, Froholm LO. Clones of serogroup B Neisseria meningitidis causing systemic disease in the Netherlands, 1958-1986. J Infect Dis 1990;162:867-74.
56. Caugant DA, Kristiansen B-E, Froholm LO, Bovre K, Selander RK. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun 1988;56:2060-8.
57. Ashton FE, Ryan JA, Borczyk A, Caugant DA, Mancino L, Huang D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 1991;29:2489-93.
58. Tavares Sacchi C, Cobo Zanella R, Caugant DA, et al. Emergence of a new clone of serogroup C Neisseria meningitidis in Sao Paulo, Brazil. J Clin Microbiol 1992;30:1282-6.
59. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA 1995;383-9.
60. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: emergence of a virulent clone of Neisseria meningitidis. JAMA 1995;273:390-4.
61. Olyhoek T, Crowe BA, Achtman M. Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev Infect Dis 1987;9:665-92.
62. Achtman M. Clonal spread of serogroup A meningococci: a paradigm for the analysis of microevolution in bacteria. Mol Microbiol 1994;11:15-22.
63. Achtman M. Epidemic spread and antigenic variability of Neisseria meningitidis. Trends Microbiol 1995;3:186-192.
64. Achtman M, Kusecek B, Morelli G, et al. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis 1992;165:53-68.
65. Crowe BA, Wall RA, Kusecek B, et al. Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. J Infect Dis 1989;159:686-700.
66. Wang J-F, Caugant DA, Li X, Hu X, Poolman JT, Crowe BA, et al. Clonal and antigenic analysis of serogroup A. Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun 1992;60:5267-82.
67. Morelli G, del Valle J, Lammel CJ, et al. Immunogenicity and evolutionary variability of epitopes within IgA1 proteases from serogroup A Neisseria meningitidis. Mol Microbiol 1994;11:175-87.
68. Suker J, Feavers IM, Achtman M, Morelli G, Wang J-F, Maiden MGJ. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 1994;12:253-65.
69. Caugant DA, Mocca LF, Frasch CE, Froholm LO, Zollinger WD, Seiander RK. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 1987;2781-92.
70. Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 1989;2:260-3.
71. Riou JY, Caugant DA, Selander RK, Poolman JT, Guibourdenche M, Collatz E. Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur J Clin Microbiol Infect Dis 1991;10:405-9.
72. Salih MAM, Danielsson D, Backman A, Caugant DA, Achtman M, Olcen P. Characterization of epidemic and non-epidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol 1990;28:1711-9.
73. Pinner RW, Onyango F, Perkins BA, et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. J Infect Dis 1992;166:359-64.
74. Stevens DL, Tanner MH, Winship J, et al. Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome. N Engl J Med 1989;321:1-7.
75. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990;336:1167-1171.
76. Kohler W, Gerlach D, Knoll H. Streptococcal outbreaks and erythrogenic toxin A. Zbl Bakt Hyg 1987;266:104-15.
77. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990;22:421-9.
78. Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group Astreptococcal infections in Sweden, 1988-1989. J Infect Dis 1992;166:31-7.
79. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993;167:1112-7.
80. Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G. Increasing severity of invasive group Astreptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 1995;21:1220-7.
81. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993;269:390-1.
82. Musser JM, Hauser AR, Kam MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991;88:2668-72.
83. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995;994-1003.
84. Nelson K, Schlievert PM, Selander RK, Musser JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med 1991;174:1271-4.
85. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993;167:337-46.
86. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-10.
87. Kline JB, Collins CM. Structure-function analysis of streptococcal pyrogenic exotoxin A (SpeA). In: Proceedings of the Annual Meeting of the American Society for Microbiology. Abstract B-59.
88. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
89. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989;38(suppl S-3):1-25.
90. Centers for Disease Control. Expanded tuberculosis surveillance and tuberculosis morbidity - United States, 1993. MMWR 1994;43:361-6.
91. Kapur V, Whittam TS, Musser JM. Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis 1994;170:1348-9.
92. Heym B, Alzari PM, Honore N, Cole ST. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid- resistance in Mycobacterium tuberculosis. Mol Microbiol 1995;15:235-45.
93. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
94. Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JDA. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 1996;173:196-202.
95. Wilson TM, de Lisle GW, Collins DM. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 1995;15:1009-15.
96. Ayvazian LF. History of tuberculosis. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, 1993:1-20.
97. Salo WL, Aufderheide AC, Buikstra J, Holcomb TA. Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl Acad Sci USA 1994;91:2091-4.
98. Ross BC, Raios K, Jackson K, et al. Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool. J Clin Microbiol 1992;30:942-6.
99. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
100. Webb GB. Tuberculosis. New York: Hoeber, 1936.
101. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampin- resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-50.
102. Kapur V, Li LL, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase b subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-8.
103. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71.
104. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
105. Bifani P, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. JAMA. In press.
106. Sullivan EA, Kreiswirth BN, Palumbo L, Kapur V, Musser JM, Ebrahimzadeh A, Frieden TR. Emergence of fluoroquinolone- resistant tuberculosis in New York City. Lancet 1995;345:1148-50.
107. Plikaytis BB, Marden JL, Crawford JT, et al. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol 1994;32:1542-6.
108. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994;170:151-6.
109. Longuet P, Pierre J, Lacassin F, et al. A limited multidrug- resistant Mycobacterium tuberculosis (MDR-TB) outbreak. Screening of hospitalized patients (pts). Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995;Abstract J59.
110. Chretien J, Holland W, Macklem P, Murray P, Woolcock A. Acute respiratory infections in children: a global public-health problem. N Engl J Med 1984;310: 982-984.
111. Monto AS. Acute respiratory infection in children of developing countries: challenge of the 1990s. Rev Infect Dis 1989;11:498-505.
112. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986;5:247-52.
113. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults. Ann Intern Med 1988;108:616-25.
114. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
115. Fenoll A, Martin-Bourgon C, Munoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic disease in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
116. Marton A, Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
117. Jabes D, Nachman S, Tomasz A. Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J Infect Dis 1989;159:16-25.
118. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol 1993;9:635-43.
119. Dowson CG, Hutchison A, Spratt BG. Extensive remodelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol Microbiol 1989;3:95-102.
120. Dowson CG, Hutchison A, Brannigan JA, George RC, Hansman D, Linares J, et al. Horizontal transfer of penicillin-binding protein genes in penicillin- resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989;86:8842-6.
121. Dowson CG, Hutchison A, Woodford N, Johnson AP, George RC, Spratt BG. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1990;87:5858-62.
122. Laible G, Hakenbeck R, Sicard MA, Joris B, Ghuysen J-M. Nucleotide sequences of the pbpX genes encoding the penicillin- binding proteins 2x from Streptococcus pneumoniae R6 and a cefotaxime-resistant mutant, C506. Mol Microbiol 1989;3:1337-48.
123. Laible G, Spratt BG, Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin- resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991;5:1993-2002.
124. Humbert O, Prudhomme M, Hakenback R, Dowson CG, Claverys J-P. Homologous recombination and mismatch repair during transformation in Streptococcus pneumoniae: saturation of the hex mismatch repair system. Proc Natl Acad Sci USA 1995;92:9052-6.
125. Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302-6.
126. Munoz R, Musser JM, Grain M, Briles DE, Marton A, Parkinson AJ, et al. Geographic distribution of penicillin- resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 1992;5:112-8.
127. Versalovic J, Kapur V, Mason EO Jr, Shah U, Koeuth T, Lupski JR, et al. Penicillin-resistant Streptococcus pneumoniae strains recovered in Houston: identification and molecular characterization of multiple clones. J Infect Dis 1993;167:850-6.
128. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993;168:158-63.
129. Sibold C, Wang J, Henrichsen J, Hakenbeck R. Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents. Infect Immun 1992;60:4119-26.
130. Kell CM, Jordens JZ, Daniels M, Coffey TJ, Bates J, Paul J, et al. Molecular epidemiology of penicillin-resistant pneumococci isolated in Nairobi, Kenya. Infect Immun 1993;61:4382-91.
131. McDougal LK, Facklam R, Reeves M, Hunter S, Swenson JM, Hill BC, et al. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother 1992;36:2176-84.
132. Kristinsson KG, Hjalmarsdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992;339:1606-7.
133. Nordic Statistics on Medicines 1987-1989. Uppsala, Sweden: Nordiska Lakemedelsnamnden, Nordic Council on Medicines, 1990: 66-71. NLN publication no. 30.
134. Col NF, O'Connor RW. Estimating worldwide current antibiotic usage: report of task force 1. Rev Infect Dis 1987; 9(suppl 3): S232-9.
135. Coffey TJ, Dowson CG, Daniels M, Zhou J, Martin C, Spratt BG, et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol 1991;5:2255-60.
136. Lomholt H. Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae. Infect Immun 1995;63:4238-43.
137. Jevons MP. "Celbenin"-resistant staphylococci. Br Med J 1961;i:124-5.
138. Grubb WB. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. In: Novick R, Skurray RA, editors. Molecular biology of the staphylococci. New York: VCH Publishers, 1990:595-606.
139. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. J Bacteriol 1984;158:513-6.
140. Matsuhashi M, Song MD, Ishino F, Wachi M, Doi M, Inoue M, et al. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to β-lactam antibiotics in Staphylococcus aureus. J Bacteriol 1986;167:975-80.
141. Song MD, Maesaki S, Wachi M, Takahashi T, Doi M, Ishino F, et al. Primary structure and origin of the gene encoding the β-lactam-inducible penicillin-binding protein responsible for methicillin-resistance in Staphylococcus aureus. In: Actor P, Daneo-Moore L, Higgins ML, Salton MRJ, Shockman GD, editors. Antibiotic inhibition of bacterial cell surface assembly and function. Washington, DC: American Society for Microbiology, 1988;352-9.
142. Song MD, Wachi M, Doi M, Ishino F, Matsuhashi M. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett 1987;221:167-71.
143. Musser JM, Selander RK. Genetic analysis of natural populations of Staphylococcus aureus. In: Novick R, Skurray RA, editors. Molecular biology of the staphylococci. New York: VCH Publishers, 1990:59-67.
144. Musser JM, Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30:2058-63.
145. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993;259:227-30.
146. Boerlin P, Peter O, Bretz AG, Postic D, Baranton G, Piffaretti J- C. Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun 1992;60:1677-83.
147. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti J-C, Assous M, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992;42:378-83.
148. Marconi RT, Garon CF. Identification of a third genomic group of Borrelia burgdorferi through signature nucleotide analysis and 16S rRNA sequence determination. J Gen Microbiol 1992;138:533-6.
149. Welsh J, Pretzman C, Postic D, Saint Girons I, Baranton G, McClelland M. Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int J Syst Bacteriol 1992;42:370-7.
150. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations. Clin Infect Dis 1993;17:708-17.
151. Balmelli T, Piffaretti J-C. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995;146:329-40.
152. Assous MV, Postic D, Paul G, Nevot P, Baranton G. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis 1993;12:261-8.
153. Wachsmuth IK, Evins GM, Fields PI, et al. The molecular epidemiology of cholera in Latin America. J Infect Dis 1993;167:621-6.
154. Wachsmuth K, Olsvik O, Evins GM, Popovic T. Molecular epidemiology of cholera. In: Wachsmuth IK, Blake PA, Olsvik O, editor. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994;357-70.
155. Faruque SM, Abdul Alim ARM, Rahman MM, Siddique AK, Sack RB, Albert MJ. Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J Clin Microbiol 1993;31:2513-2516.
156. Musser JM, Kroll JS, Granoff DM, et al. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis 1990;12:75-111.
157. Piffaretti JC, Kressebuch H, Aeschbacher M, Bille J, Bannerman E, Musser JM, et al. Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc Natl Acad Sci USA 1989;86:3818-22.
158. Bibb WF, Gellin BG, Weaver R, Schwartz B, Plikaytis BD, Reeves MW, et al. Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol 1990;56:2133-41.
159. Selander RK, Smith NH. Molecular population genetics of Salmonella. Rev Med Microbiol 1990;1:219-28.
160. Selander RK, Li J, Boyd EF, Wang F-S, Nelson K. DNA sequence analysis of the genetic structure of populations of Salmonella enterica and Escherichia coli. In: Priest FG, Ramos-Cormenzana A, Tindall BJ, editors. Bacterial diversity and systematics. New York: Plenum, 1994;17-49.
161. Selander RK, Beltran P, Smith NH, et al. Evolutionary genetic relationships of clones of Salmonella serovars causing human typhoid and other enteric fevers. J Bacteriol 1990;58:1891-1901.
162. Selander RK, Musser JM. Population genetics of bacterial pathogenesis. In: Clark V, Iglewski B, editor. Molecular basis of bacterial pathogenesis. San Diego: Academic Press, 1990;11-36.
163. Fleischmann RD, Adams MD, White O, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995;269:496-512.
164. Fraser CM, Gocayne JD, White O, et al. The minimal gene complement of Mycoplasma genitalium. Science 1995;270:397-403.